| Name | Title | Contact Details |
|---|
Calypte Biomedical Corporation is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Portland, OR. To find more information about Calypte Biomedical Corporation, please visit www.calypte.com
StoneCrest Medical Center offers acute care services including emergency and intensive care, general surgery, cardiology, obstetrics, physical medicine, outpatient diagnostic services and cancer care. From the newest in cardiac ultrasound technology to the state-of-the-art catheterization lab, TriStar StoneCrest is equipped to deliver a range of services to help prevent, treat, and recover from heart disease and stroke. From screenings to diagnostic cardiac catheterization, from angioplasty to rehabilitation, TriStar StoneCrest`s services have earned a reputation for excellence.
Liberty HomeCare & Hospice Services is a Wilmington, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Healthcare Bluebook`s goal is to protect consumers and companies nationwide from overpriced, low-quality healthcare. Using industry-leading objective price and quality data and claims-driven ROI reporting, Bluebook`s intuitive online healthcare shopping solution provides 7,000+ employers and members with an easy-to-use benefits solution that increases movement to high-value care, driving savings and rapid ROI, and provides greater price predictability. Combined with a proven engagement methodology, Bluebook`s innovative suite of services empowers employees to become smarter healthcare shoppers, while decreasing costs and improving healthcare outcomes.
Cleveland BioLabs, Inc. (NASDAQ: CBLI) is an innovative bio pharmaceutical company developing novel approaches to activate the immune system and address serious medical needs. Our proprietary platform of toll-like immune receptor activators has applications in radiation mitigation, oncology immunotherapy, and vaccines. We combine our proven scientific expertise and our depth of knowledge about our products’ mechanisms of action into a passion for developing drugs to save lives. Our proprietary drug candidates act via unique mechanisms that are designed to kill cancer and protect healthy cells. Our most advanced product candidate is entolimod, which we are developing as a radiation countermeasure and an immunotherapy for oncology and other indications. We have additional pipeline product candidates in various stages of development.